Search clinical trials for: Inhaled amphotericin

Total 1174 results

PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
Banaras Hindu University
Rajendra Memorial Research Institute of Medical Sciences

Unknown

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Visceral Leishmaniasis

India
Postgraduate Institute of Medical Education and...

Completed

A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis

India
Fovea
Gilead Sciences

Unknown

Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients (AMBIDEX)

Sepsis | Candida

France
Postgraduate Institute of Medical Education and...

Completed

Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis

Pulmonary Mucormycosis

India
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Bharat Serums and Vaccines Limited
Ministry of Science and Technology

Completed

To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar

Leishmaniasis, Visceral

India
Aurobindo Pharma Ltd
Axis Clinicals Limited

Completed

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

Visceral Leishmaniasis

Bangladesh, India
Astellas Pharma Global Development, Inc.

Terminated

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis (MAGIC-2)

Candidiasis

Philippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
Southeast University, China

Completed

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

Fungal Infection

China
Synspira, Inc.

Terminated

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Lung Diseases | Cystic Fibrosis | Pulmonary Disease | Antibiotic Resistant Infection | Respiratory Tract Disease | Cystic Fibrosis Pulmonary Exacerbation | Lung Inflammation | Burkholderia Infections | Lung Infection | Multi-antibiotic Resistance | Pulmonary Inflammation | Lung Infection Pseudomonal | Cystic Fibrosis... and other conditions

United Kingdom
Liposome

Completed

Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome

HIV Infections | Meningitis, Cryptococcal

United States
Peking Union Medical College Hospital

Recruiting

To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD

Invasive Fungal Disease

China
Taiwan Liposome Company

Completed

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Normal Healthy Subjects
European Organisation for Research and Treatment...

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Cancer

Belgium, Netherlands, Italy, Hungary, France, Spain, Germany, Israel, Czech Republic, United Arab Emirates, Sweden, Greece, Turkey, Portugal, Slovakia
Banaras Hindu University

Completed

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Visceral Leishmaniasis

India
Matinas BioPharma Nanotechnologies, Inc.

Completed

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis (CAMB)

Candidiasis, Chronic Mucocutaneous

United States
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Withdrawn

Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection (ORACLE)

Cryptococcal Infections
Hospital Universitário Professor Edgard Santos

Completed

Liposomal Amphotericin in Disseminated Leishmaniasis

Disseminated Leishmaniasis

Brazil
Drugs for Neglected Diseases

Completed

Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia (Anfoleish)

Cutaneous Leishmaniasis

Colombia
Drugs for Neglected Diseases
Addis Ababa University

Terminated

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Visceral Leishmaniasis

Ethiopia, Sudan
GlaxoSmithKline

Completed

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Pulmonary Disease, Chronic Obstructive

Czechia, Hungary
GlaxoSmithKline

Completed

A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

Hungary, Slovakia
Matinas BioPharma Nanotechnologies, Inc.
University of Cologne; The Clinical Trials Centre Cologne

Withdrawn

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever

Neutropenia and Fever
Hospital Universitário Professor Edgard Santos
Instituto Gonçalo Muniz FIOCRUZ BA

Completed

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Cutaneous Leishmaniasis, American

Brazil
Poitiers University Hospital

Recruiting

Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole

Chronic Pulmonary Aspergillosis

France
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Completed

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (EnACT)

Cryptococcal Meningitis

Uganda
TTY Biopharm

Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

Neutropenia, Febrile

Taiwan
Fundació Sant Joan de Déu
Ministry of Health, Spain

Completed

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Lymphoblastic Leukemia | Invasive Pulmonary Aspergillosis | Lymphoblastic Leukaemia | Myeloblastic Leukaemia | Myeloblastic Leukemia

Spain
Galecto Biotech AB

Completed

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Banaras Hindu University

Completed

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

Visceral Leishmaniasis

India
Gilead Sciences

Terminated

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Febrile Neutropenia

Greece
Post Graduate Institute of Medical Education and...

Recruiting

A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Increasing Time to Relapse in Patients With Chronic Pulmonary Aspergillosis Treated With 12 Months of Oral Itraconazole (NAB-CPA)

Chronic Pulmonary Aspergillosis | Aspergilloma | CPA

India
Banaras Hindu University

Completed

Amphotericin B Treatment in Visceral Leishmaniasis

Visceral Leishmaniasis

India
Banaras Hindu University
Drugs for Neglected Diseases; Rajendra Memorial Research Institute of Medical...

Completed

Combination Therapy in Indian Visceral Leishmaniasis

Leishmaniasis, Visceral

India
Makerere University
University of Copenhagen

Completed

Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial (ICS)

Bacterial Pneumonia | Acute Asthma | Viral Pneumonia

Uganda
Soroka University Medical Center

Completed

Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis

Leishmaniasis

Israel
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)

Zygomycosis

France
Erasmus Medical Center
Gilead Sciences; Nexstar Pharmaceuticals

Completed

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Aspergillosis

Netherlands
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) (NAIFI01)

Invasive Pulmonary Aspergillosis

Spain
TTY Biopharm

Unknown

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Cryptococcal Meningitis

Taiwan
Matinas BioPharma Nanotechnologies, Inc.

Withdrawn

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Vulvovaginitis | Candidiasis, Vulvovaginal | Vulvovaginal Candidiases | Yeast Infection | Yeast Infection Vaginal

United States
University of Brasilia
Ministry of Health, Brazil

Completed

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children (LVTO)

Visceral Leishmaniasis

Brazil
Merck Sharp & Dohme LLC

Completed

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Aspergillosis
Drugs for Neglected Diseases
London School of Hygiene and Tropical Medicine; Institute of Tropical Medicine... and other collaborators

Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Visceral Leishmaniasis

Ethiopia
Poitiers University Hospital

Completed

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). (NEBULAMB)

Allergic Bronchopulmonary Aspergillosis

France
Bill McGhee
Astellas Pharma Inc

Completed

Antifungal Locks to Treat Fungal-related Central Line Infections

Central Line Fungal Infections

United States
Drugs for Neglected Diseases
International Centre for Diarrhoeal Disease Research, Bangladesh; Shaheed Surhawardy...

Completed

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Visceral Leishmaniasis

Bangladesh
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.

Cough

United Kingdom

Search clinical trials for: Inhaled amphotericin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations